Publications by authors named "Bi-cheng Wang"

Claim this Profile
D
Deciphering the biochemical functions and nucleotide sugar donor specificity determinants of dicot GT61 glycosyltransferases involved in xylan substitutions.
Ruiqin Zhong, Dayong Zhou, Dennis R Phillips, Earle R Adams, Bi-Cheng Wang

Plant Cell Physiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correspondence on 'Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study' by Smeenk .
Bi-Cheng Wang

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Storage of the vital metal tungsten in a dominant SCFA-producing human gut microbe and implications for other gut microbes.
Nana Shao, Dayong Zhou, Gerrit J Schut, Farris L Poole, Sydney B Coffey, Bi-Cheng Wang

mBio· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer.
Bi-Cheng Wang

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria.
Bi-Cheng Wang

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
{Rmerg, Rmeas, Rpim, CC1/2} for Crystal Diffraction Data Quality Evaluation.
Zheng-Qing Fu, Brian V Geisbrecht, Samuel Bouyain, Fred Dyda, John Chrzas, Bi-Cheng Wang

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: effects of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer-a prospective observation study.
Bi-Cheng Wang

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis.
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, Chen Fu

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of glycosyltransferases mediating 2-O-arabinopyranosyl and 2-O-galactosyl substitutions of glucuronosyl side chains of xylan.
Ruiqin Zhong, Dayong Zhou, Dennis R Phillips, Earle R Adams, Lirong Chen, Bi-Cheng Wang

Plant J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies.
Bo-Hua Kuang, Wen-Xuan Zhang, Guo-He Lin, Chen Fu, Ru-Bo Cao, Bi-Cheng Wang

Front Endocrinol (Lausanne)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies.
Ru-Bo Cao, Yao Ge, Wen-Xuan Zhang, Guo-He Lin, Bo-Hua Kuang, Bi-Cheng Wang

Medicine (Baltimore)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant Cell Wall Polysaccharide -Acetyltransferases.
Ruiqin Zhong, Dayong Zhou, Lirong Chen, John P Rose, Bi-Cheng Wang

Plants (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies.
Bi-Cheng Wang, Guo-He Lin, Bo-Hua Kuang, Ru-Bo Cao

Front Endocrinol (Lausanne)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of pyrotinib for HER‑2‑positive breast cancer in the neoadjuvant setting: A systematic review and meta‑analysis.
Qian Ma, Bai Wei, Bi-Cheng Wang, Ganxin Wang, Xuan Zhou, Yan Wang

Oncol Lett· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rice GT61 glycosyltransferase possesses dual activities mediating 2-O-xylosyl and 2-O-arabinosyl substitutions of xylan.
Ruiqin Zhong, Dayong Zhou, Dennis R Phillips, Earle R Adams, Lirong Chen, Bi-Cheng Wang

Planta· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World Studies.
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin

Target Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer: a survival analysis of reconstructed patient-level data.
Bi-Cheng Wang, Chen Fu, Guo-He Lin

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel-fosfamide monotherapy or in combination with doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcoma: A pooled analysis of randomized clinical trials.
Xin-Xiu Liu, Yan-Hong Han, Bo-Hua Kuang, Guo-He Lin, Bi-Cheng Wang

Medicine (Baltimore)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating radiation‑related nasopharyngeal necrosis with endostar in patient with nasopharyngeal carcinoma: A report of two cases and a literature review.
Jie Tang, Xiu-Wen Li, Yong Wu, Zhen Su, Yan He, Bi-Cheng Wang

Mol Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer.
Shao-Xian Cheng, Qiu-Chi Chen, Guo-He Lin, Yan-Hong Han, Bi-Cheng Wang

Medicine (Baltimore)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and tumor mutational burden in cancer patients with liver metastases: A meta and real word cohort analysis.
Rui-Yan Wu, Bi-Cheng Wang, Kun Wang, Fan Xia, Zhi-Yuan Zhang

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poziotinib in non-small-cell lung cancer patients with HER2 exon 20 mutations: A pooled analysis of randomized clinical trials.
Bi-Cheng Wang, Bo-Hua Kuang, Xin-Xiu Liu, Guo-He Lin

Medicine (Baltimore)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer.
Xin-Xiu Liu, Guo-He Lin, Bi-Cheng Wang

Medicine (Baltimore)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials.
Bi-Cheng Wang, Wen-Xuan Zhang, Bo-Hua Kuang, Guo-He Lin

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Alone or in Combination with Stereotactic Body Radiotherapy in Advanced Lung Cancer: A Pooled Analysis of Randomized Clinical Trials.
Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin

J Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis